Under insufficient glucose availability, the level of USP7 is inhibited by p53, resulting in degradation of PRMT1 via ubiquitination of the proteasome pathway, thereby inhibiting the Warburg effect and proliferation of NSCLC cells. Here, USP7 is linked to non-small cell lung carcinoma.